NEKTAR THERAPEUTICS (NKTR)       3.1  +0.01 (+0.32%)

3.1  +0.01 (+0.32%)

US6402681083 - Common Stock

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
95.04M101.91M152.90M114.60M1.19B
Non Recurring Items
-124.35M0.00-45.20M0.000.00
Cost Of Goods
21.57M24.90M19.50M21.40M24.40M
Gross Profit
73.48M77.01M133.40M93.20M1.17B
Operating Expenses
385.73M523.11M513.30M533.30M481.00M
Operating Income
-312.26M-446.10M-379.90M-440.10M687.90M
Interest Expense
6.93M-52.77M-18.80M0.00-5.20M
Income Before Taxes
-454.09M-523.28M-443.90M-440.10M682.70M
Income Tax
67.00K557.00K500.00K600.00K1.40M
Net Income
-454.15M-523.84M-444.40M-440.70M681.30M
EBITDA
-298.97M-431.96M-365.70M-426.90M698.80M
 
Per Share Data
EPS Diluted Total Ops
-2.44-2.86-2.49-2.523.78
Non GAAP EPS
-2.44-2.85-2.24-2.513.60
 
Statistics
Gross Profit Margin
77.31%75.57%87.25%81.33%97.96%
Profit Margin
-477.85%-514.03%-290.65%-384.55%57.09%
Operating Profit Margin
-328.55%-437.76%-248.46%-384.03%57.65%

All data in USD

Charts